Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $63.12 million. The enterprise value is $71.02 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 7.02% in one year.
Current Share Class | 37.79M |
Shares Outstanding | 37.79M |
Shares Change (YoY) | +7.02% |
Shares Change (QoQ) | +6.58% |
Owned by Insiders (%) | 14.56% |
Owned by Institutions (%) | 24.46% |
Float | 25.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.31 |
Forward PS | 1.27 |
PB Ratio | 6.00 |
P/TBV Ratio | 6.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 3.66.
Current Ratio | 5.45 |
Quick Ratio | 4.49 |
Debt / Equity | 3.66 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.60 |
Financial Efficiency
Return on equity (ROE) is -129.51% and return on invested capital (ROIC) is -17.58%.
Return on Equity (ROE) | -129.51% |
Return on Assets (ROA) | -14.60% |
Return on Invested Capital (ROIC) | -17.58% |
Return on Capital Employed (ROCE) | -30.17% |
Revenue Per Employee | $214,945 |
Profits Per Employee | -$91,077 |
Employee Count | 220 |
Asset Turnover | 0.72 |
Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Apyx Medical has paid $248,000 in taxes.
Income Tax | 248,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks. The beta is 1.20, so Apyx Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.20 |
52-Week Price Change | +6.25% |
50-Day Moving Average | 1.25 |
200-Day Moving Average | 1.33 |
Relative Strength Index (RSI) | 61.18 |
Average Volume (20 Days) | 464,587 |
Short Selling Information
The latest short interest is 413,602, so 1.09% of the outstanding shares have been sold short.
Short Interest | 413,602 |
Short Previous Month | 258,778 |
Short % of Shares Out | 1.09% |
Short % of Float | 1.61% |
Short Ratio (days to cover) | 0.98 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $47.29 million and -$20.04 million in losses. Loss per share was -$0.54.
Revenue | 47.29M |
Gross Profit | 29.08M |
Operating Income | -15.28M |
Pretax Income | -28.50M |
Net Income | -20.04M |
EBITDA | -14.70M |
EBIT | -15.28M |
Loss Per Share | -$0.54 |
Full Income Statement Balance Sheet
The company has $31.01 million in cash and $38.92 million in debt, giving a net cash position of -$7.91 million or -$0.21 per share.
Cash & Cash Equivalents | 31.01M |
Total Debt | 38.92M |
Net Cash | -7.91M |
Net Cash Per Share | -$0.21 |
Equity (Book Value) | 10.64M |
Book Value Per Share | 0.28 |
Working Capital | 42.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$12.41 million and capital expenditures -$742,000, giving a free cash flow of -$13.15 million.
Operating Cash Flow | -12.41M |
Capital Expenditures | -742,000 |
Free Cash Flow | -13.15M |
FCF Per Share | -$0.35 |
Full Cash Flow Statement Margins
Gross margin is 61.49%, with operating and profit margins of -32.31% and -42.37%.
Gross Margin | 61.49% |
Operating Margin | -32.31% |
Pretax Margin | -42.07% |
Profit Margin | -42.37% |
EBITDA Margin | -31.09% |
EBIT Margin | -32.31% |
FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.02% |
Shareholder Yield | -7.02% |
Earnings Yield | -31.75% |
FCF Yield | -20.83% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 41.47% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 0.06666:1.
Last Split Date | Jan 6, 1994 |
Split Type | Reverse |
Split Ratio | 0.06666:1 |
Scores
Apyx Medical has an Altman Z-Score of -0.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.52 |
Piotroski F-Score | 1 |